Tumour vasculature - a potential therapeutic target
Open Access
- 1 August 1995
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (2), 257-267
- https://doi.org/10.1038/bjc.1995.323
Abstract
The tumour vasculature is vital for the establishment, growth and metastasis of solid tumours. Its physiological properties limit the effectiveness of conventional anti-cancer strategies. Therapeutic approaches directed at the tumour vasculature are reviewed, suggesting the potential of anti-angiogenesis and the targeting of vascular proliferation antigens as cancer treatments.Keywords
This publication has 97 references indexed in Scilit:
- Platelet-derived endothelial cell growth factor has thymidine phosphorylase activityBiochemical and Biophysical Research Communications, 1992
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Isolation of fatty acid amide as an angiogenic principle from bovine mesenteryBiochemical and Biophysical Research Communications, 1990
- In vivo Analysis of Tumor Vascularization in the RatJapanese Journal of Cancer Research, 1990
- A Comparison of the Sensitivity to Photodynamic Treatment of Endothelial and Tumour Cells in Different Proliferative StatesInternational Journal of Radiation Biology, 1990
- Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour actionEuropean Journal of Cancer and Clinical Oncology, 1989
- Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivoBiochemical and Biophysical Research Communications, 1989
- Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in MiceJNCI Journal of the National Cancer Institute, 1989
- Chemical Identification of a Tumor-Derived Angiogenic FactorScience, 1987